Mycosis fungoides (MF) is a cutaneous T-cell lymphoma associated with the invasion of transformed mature T-cells into the skin demonstrating polymorphic atrophic patches, plaques, to generalized erythrodermia.
In general, the prognosis for advanced MF patients with metastasis to other sites has been reported to be poor even when treated with systemic therapies [1, 2] . Several reports of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with both myeloablative and reduced-intensity conditioning regimens [3] [4] [5] suggest the efficacy of allo-HSCT for MF through a graft-versus-lymphoma (GVL) effect [6] .
In June 2004, a 26-year-old woman was admitted to our hospital because of generalized erythrodermia, a skin tumor of the head, and multiple lymphadenopathy.
Her medical history started from 1996 with itchy erythema diagnosed as parapsoriasis in There was no sign of MF on her skin and no lymphadenopathy on CT scan at more than 23 months after the second CR, with a Karnofsky score of 90%.
Several groups described that neither conventional chemotherapy nor high-dose chemotherapy with autologous stem cell support was sufficient for the long-term remission of MF [7, 8] . Based on the successful reports of allo-HSCT for MF and the efficacy of the withdrawal of immunosuppressants for some relapsed MF cases, the important role of the GVL effect for the control of MF is suggested [9, 10] . This is the first report of successful CBT for advanced MF with the graft-versus-MF effect.
Since cord blood is available for many patients through cord blood banks and the waiting period is relatively short, CBT could be a therapeutic option for MF patients who are candidates for allo-HSCT but lack suitable related or unrelated donors. 
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